APA (7th ed.) Citation

Metzgeroth, G., Erben, P., Teichmann, M., Hofmann, W., & Reiter, A. (2012). Limited clinical activity of nilotinib and sorafenib in FIP1L1-PDGFRA positive chronic eosinophilic leukemia with imatinib-resistant T674I mutation. Leukemia, 26(1), . https://doi.org/10.1038/leu.2011.181

Chicago Style (17th ed.) Citation

Metzgeroth, Georgia, Philipp Erben, Marion Teichmann, Wolf-Karsten Hofmann, and Andreas Reiter. "Limited Clinical Activity of Nilotinib and Sorafenib in FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukemia with Imatinib-resistant T674I Mutation." Leukemia 26, no. 1 (2012). https://doi.org/10.1038/leu.2011.181.

MLA (9th ed.) Citation

Metzgeroth, Georgia, et al. "Limited Clinical Activity of Nilotinib and Sorafenib in FIP1L1-PDGFRA Positive Chronic Eosinophilic Leukemia with Imatinib-resistant T674I Mutation." Leukemia, vol. 26, no. 1, 2012, https://doi.org/10.1038/leu.2011.181.